• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about APLS

Recent news which mentions APLS

< Previous 1 2 3 4 5 6 7 8 9 Next >
Expert Ratings for Apellis Pharmaceuticals
May 05, 2022
Tickers APLS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Tickers AGTC ALLO ALNA AMRN
Tags Penny Stocks News Small Cap
From Benzinga
Apellis Pharmaceuticals's Earnings: A Preview
May 03, 2022
Tickers APLS
Tags BZI/EP Earnings Market News
From Benzinga
Expert Ratings for Apellis Pharmaceuticals
April 14, 2022
Tickers APLS
Tags APLS BZI/AAR Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
April 14, 2022
Tickers ADYEY AEVA AMH APLS
Tags HIMS LAZR HYPR
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers AHPA APLS ASND ATHA
Tags FDA General MRK
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 23, 2022
Tickers ADGI ADTX APLS CARA
Tags BZI/TFM GLS Benzinga
From Benzinga
Why Apellis Pharmaceuticals Stock Is Falling After Hours
March 23, 2022
Tickers APLS
Tags Trading Ideas News Benzinga
From Benzinga
Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies
March 16, 2022
Tickers APLS
Tags Briefs News General
From Benzinga
Here's Why Apellis Pharmaceuticals Shares Are Rising
March 16, 2022
Tickers APLS
Tags Trading Ideas APLS Benzinga
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
March 16, 2022
Tickers ADAG APLS BCLI BNTX
Tags PFE Benzinga Top Stories
From Benzinga
Expert Ratings For Apellis Pharmaceuticals
March 07, 2022
Tickers APLS
Tags Market News Analyst Ratings Benzinga
From Benzinga
Where Apellis Pharmaceuticals Stands With Analysts
March 07, 2022
Tickers APLS
Tags BZI/AAR Benzinga APLS
From Benzinga
Apellis Pharmaceuticals: Q4 Earnings Insights
February 28, 2022
Tickers APLS
Tags APLS Benzinga Earnings
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags HNI AMRC USER
From Benzinga
Apellis Pharmaceuticals's Earnings Outlook
February 25, 2022
Tickers APLS
Tags Earnings BZI/EP Market News
From Benzinga
Where Apellis Pharmaceuticals Stands With Analysts
January 11, 2022
Tickers APLS
Tags Market News Analyst Ratings Benzinga
From Benzinga
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
December 15, 2021
Tickers APLS BIOVF
Tags Briefs Blood Disorders BIOVF
From Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
Tickers ABBV APLS AVIR CALT
Tags EGRX Offerings Market News
From Benzinga
What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals
December 08, 2021
Tickers APLS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
Tickers ALLE ALLT AMPL APLS
Tags GLBE ALLE AWR
From Benzinga
Analyst Ratings For Apellis Pharmaceuticals
November 29, 2021
Tickers APLS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
Tickers ACXP ADGI AFRM ALLE
Tags EVO WFC ARHS
From Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
Tickers ABT AMRN APLS BIIB
Tags Offerings NRXP NASDAQ
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 15, 2021
Tickers APLS BBLG ETON EVOK
Tags APLS Market News BBLG
From Benzinga
Where Apellis Pharmaceuticals Stands With Analysts
November 09, 2021
Tickers APLS
Tags Benzinga BZI/AAR APLS
From Benzinga
Cramer Likes DraftKings, Skyworks, And These Automakers
October 07, 2021
Tickers APLS BGS CPB DKNG
Tags REGN CNBC TSLA
From Benzinga
Is Good News Enough for You to Buy NGM on the Dip?
October 06, 2021
Tickers APLS MRK NGM
Tags APLS NGM MRK
From Motley Fool
Raymond James Upgraded This Biopharma Stock And Sees 44% Upside
September 13, 2021
Tickers APLS NGM
Tags General Price Target NGM
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
Tickers ABUS ADGI AFRM AMRK
Tags GEVO SPIR ENDP
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap